Ikhaya NomkhayaSokukhulelwa

Grippferon ngesikhathi sokukhulelwa - umuthi best ngokumelene umkhuhlane futhi imikhuhlane.

Abesifazane abakhulelwe kufanele bavikeleke ezihlukahlukene izifo ukuthi abazange babe nanoma yiziphi izinkinga abantwana, ukuthi umntwana wazalwa enempilo. Owesifazane yesimanje abakwazi ukuhlala ekhaya, ukuze igciwane abakutholanga emzimbeni wakhe. Futhi kaningi ngesikhathi sokukhulelwa, abaningi bahlushwa ezihlukahlukene izifo ezithathelwanayo, uzama ukucosha ekwelapheni umuthi onjalo, ukuze singathwesi umonakalo ekwakheni ikusasa ingane.

Izinto zesimanje emakethe izidakamizwa egcwele izindlela ezihlukene ukuze ukulwa nezifo. Ngaphambi owesifazane engatholi akuwona neze umsebenzi olula ukukhetha ngempumelelo kakhulu futhi ngesikhathi esifanayo nemithi ephephile. Grippferon ngesikhathi ukhulelwe isidakamizwa esingenangozi njengoba hhayi kuphela ngempumelelo, kodwa futhi. izingxenye zalo etholakala ngokuzikhandla indlela isakhi sokuzakhela. Isakhi esiyinhloko umuthi interferon. Izazi zezakhi zofuzo bakubiza isakhi sokuzakhela interferon alfa-2b. Grippfernon ngesikhathi sokukhulelwa kuvimbela ekwandeni amagciwane ahlukene ukuthi ufake umzimba by ephefumula umoya.

Umuthi itholakala ngendlela amathonsi acinene. Drops Grippferon ngesikhathi sokukhulelwa lisetshenziswe ekwelapheni SARS, izifo sibi zokuphefumula futhi umkhuhlane. Umuthi uqala ukusebenza ngisho nalapho lingena le mucosa acinene. Akasiniki igciwane lande endaweni ababehleleké kuyo ukungena emzimbeni.

Indlela yokusebenzisa Grippferon phakathi nenkathi yokukhulelwa?

Grippferon kwabesifazane abakhulelwe nakanjani ephephile ekwelapheni izifo ezibangelwa amagciwane, ngoba azikho izinto eziyingozi noma ayingozi. Ngaphezu kwalokho, ngokuvamile kakhulu Kunconywa prophylaxis ngesikhathi isimo okungekuhle epidemiological esifundeni noma izwe. Abantu ezenza okuqhubekayo esikuyo abakhulelwe: umndeni, ozakwabo, Ungase futhi usebenzise lesi izidakamizwa ukuze kuvinjelwe futhi kwelashwe. Iphuzu liwukuthi kakade ngosuku kwesicelo wesibili kusho okumbalwa amagciwane ngamakhala. Lokhu kunciphisa ingozi yesifo e abantu abangekho nabo isiguli.

Lapho owesifazane enezinwele izimpawu zokuqala zesifo, yena Kuyaphuthuma ukusebenzisa amathonsi acinene. Esikhathini ekhaleni wangcwatshwa amathonsi ezintathu esikhathini amahora amathathu noma amane. Lokhu nqubo yokwelapha ithatha izinsuku ezinhlanu. Ngemva instillation zomuthi phakathi komgodi acinene, ke massaged kwamaphiko ekhaleni ngeminwe yakho. Kubalulekile ukusatshalaliswa umfaniswano izidakamizwa e ngalo ingaphakathi acinene. Grippferon sokukhulelwa uyangiduduza esizayo onesifo umama cishe ngokushesha. Ikhala elivuzayo nezinkinga ukukhwehlela ziyancipha, ikhanda ayeke.

Lapho ukwelashwa sekudlulile we amathonsi akhethiwe kanti lesi sifo ngeke zingancishiswa ngokushintsha cishe 40%. Ingozi yezinkinga SARS sehliselwe 70%. Ukusebenzisa Grippferon ngesikhathi sokukhulelwa, isiguli ayidingi imithi eyengeziwe. Antipyretics zithathwe uma kwenzeka fever kwabesifazane abakhulelwe. Azikho Izimo izidakamizwa uma isetshenziswa kanye nezinye izidakamizwa. Kuyinto iyahambisana kahle zonke imithi.

Grippferon - umuthi eyingqayizivele ukwelapha umkhuhlane ne-SARS.

Acinene lehla Grippferon ngesikhathi sokukhulelwa akudingeki analogue ku imithi emakethe emhlabeni. Lena izidakamizwa ehlukile kuthinta lenqwaba izifo ezibangelwa amagciwane adluliselwa zokuphefumula. It kungokwalabo isizukulwane esisha izidakamizwa. ehlukile yayo itholakala ikhono ukuvimba interferon izindlela okuzala ka-virus, kodwa hhayi uxhumana nabo. Kuyinto osebenzayo for bonke ubudala. It ezinqunyiwe ukwelashwa kanye nokuvimbela hhayi kuphela kwabesifazane abakhulelwe, kodwa futhi izingane ezincane.

Umuthi iphephile, uma ulandela imiyalelo ukusetshenziswa. Ngakho-ke, self-iqondiswa amathonsi acinene futhi sibanikeze akuvumelekile, ikakhulukazi kumama. Ngaphambi kokusebenzisa imithi kumele uxhumane nongoti yabo obelethisayo noma jikelele.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 zu.birmiss.com. Theme powered by WordPress.